Globeflex Capital’s AbbVie ABBV Stock Holding History

Globeflex Capital’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-82	Closed	-$9K	–	457
2021 Q3	$9K	Hold	82	–	–	﹤0.01%	408
2021 Q2	$9K	Hold	82	–	–	﹤0.01%	426
2021 Q1	$9K	Hold	82	–	–	﹤0.01%	424
2020 Q4	$9K	Hold	82	–	–	﹤0.01%	434
2020 Q3	$7K	Buy	82 +16	+24%	+$1.51K	﹤0.01%	429
2020 Q2	$6K	Hold	66	–	–	﹤0.01%	454
2020 Q1	$5K	Hold	66	–	–	﹤0.01%	462
2019 Q4	$6K	Hold	66	–	–	﹤0.01%	458
2019 Q3	$5K	Hold	66	–	–	﹤0.01%	450
2019 Q2	$5K	Buy	+66	New	+$5.19K	﹤0.01%	444
2013 Q4	–	Sell	-53	Closed	-$2K	–	609
2013 Q3	$2K	Hold	53	–	–	﹤0.01%	418
2013 Q2	$2K	Buy	+53	New	+$2.32K	﹤0.01%	414

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Globeflex Capital's ABBV Position: Q4 2021 in Review

Globeflex Capital sold out of AbbVie (ABBV) in Q4 2021, closing a stake of 82 shares — an estimated $9K sold.

Globeflex Capital first reported a position in ABBV in Q2 2013 and held it in 12 quarters. The position peaked at $9K in Q3 2021. 2,981 funds tracked by Wall St. Rank hold ABBV as of Q4 2021.

Globeflex Capital reported no remaining AbbVie position as of Q4 2021 after selling out during the quarter.
Globeflex Capital sold 82 AbbVie shares in Q4 2021, an estimated $9K.
Globeflex Capital first reported a position in AbbVie in Q2 2013 and held it in 12 quarters.
Globeflex Capital's AbbVie position peaked at $9K in Q3 2021.
2,981 funds tracked by Wall St. Rank held AbbVie as of Q4 2021.

Based on Globeflex Capital's 13F filing for Q4 2021, filed 10 Feb 2022.